Patent · US Active

Anti-hemagglutinin antibodies and methods of use thereof

US11773156B2 · kind B2 · utility

0Cited by
6References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2020
Grant dateOct 3, 2023
Priority date—
Expiry dateNov 13, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/33
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza B hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies are useful for inhibiting or neutralizing influenza B virus activity, thus providing a means of treating or preventing influenza infection in humans. Also provided is the use of one or more antibodies that bind to the influenza B HA for preventing viral attachment and/or entry into host cells. The antibodies may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.